Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
In recent years, early intervention services have attempted to identify people with a first episode of psychosis as early as possible, reducing the duration of untreated psychosis and changing the timing of delivery of interventions. The logic of early intervention is based partly on accessing people in a more treatment responsive stage of illness in which psychosocial damage is less extensive, and partly on remediating a putatively active process of neuroprogression that leads to pathophysiological, symptomatic and structural changes, hence improving symptomatic and functional outcomes. However, as in other areas of health care, earlier identification of new patients may mean that different treatment approaches are indicated. The corollary of early detection is that the sequence and complexion of treatment strategies for first episode psychosis has been revaluated. Examples include the minimal effective dosage of antipsychotic medication and the content of psychosocial interventions. With the substantial reductions of DUP now seen in many early psychosis services, based on clinical staging and stepped care principles, it is even possible that the immediate introduction of antipsychotic medication may not be necessary for all first episode psychosis cases, but that potentially safer interventions, which may be more acceptable to many patients, such as comprehensive psychosocial intervention, may constitute effective treatment at least for a subgroup of patients. In this paper, we review this theoretical background and describe a randomised controlled trial currently underway at the Early Psychosis Prevention and Intervention Centre (EPPIC) in Melbourne designed to test outcomes for first episode psychosis patients in response to two different treatments: intensive psychosocial intervention plus antipsychotic medication versus intensive psychosocial intervention plus placebo. This is a theoretically and pragmatically novel study in that it will provide evidence as to whether intensive psychosocial intervention alone is sufficient for a subgroup of first episode psychosis patients in a specialised early intervention service, and provide a test of the heuristic clinical staging model. By experimentally manipulating duration of untreated psychosis, the study will also provide a methodologically strong test of the effect of delaying the introduction of antipsychotic medication, as well as helping to disentangle the effects of antipsychotic medications and the putative neurobiological processes associated with brain changes and symptom profiles in the early phase of psychotic disorders. The study has been carefully crafted to satisfy critical ethical demands in this challenging research domain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 2×
“, 2008b), inflammatory cytokines (Miller et al., 2009) and lipid”
BackgroundTHE CONTINUITY OF PSYCHOTIC EXPERIENCES IN THE GENERAL POPULATION
Johns, L. C., & van Os, J. (2001) · Clinical Psychology Review · doi:10.1016/s0272-7358(01)00103-9 · Cited by 960
Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.192 · Cited by 896
Self-citationStrauss (1969) revisited: a psychosis continuum in the general population?
van Os, J., Hanssen, M., Bijl, R. V., & Ravelli, A. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00224-8 · Cited by 893
Cognitive approaches to delusions: a critical review of theories and evidence.
Garety, P. A., & Freeman, D. (1999) · British Journal of Clinical Psychology · doi:10.1348/014466599162700 · Cited by 794 · cited 2×
“and promoting insight into illness (Garety et al., 2000; Garety and Freeman, 1999; Morrison, 2001, 2002).”
BackgroundThe STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Morrison, A. P. (2001) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465801003010 · Cited by 673 · cited 1×
“…largely involves utilising strategies for managing positive psychotic symptoms, such as identifying and changing cognitive styles and behavioural patterns that may contribute to these symptoms, and promoting insight into illness (Garety et al., 2000; Garety and Freeman, 1999; Morrison, 2001, 2002).”
BackgroundEarly intervention in psychosis: concepts, evidence and future directions
MCGORRY, P. D., KILLACKEY, E., & YUNG, A. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00182.x · Cited by 581 · cited 2×
“Clinical staging differs from conventional diagnostic practice in that it defines the extent of progression of disease at a particular point in time, and where a person currently lies along the continuum of the course of illness (McGorry et al., 2008).”
BackgroundMethodSelf-citationScott, J., Paykel, E., Morriss, R., Bentall, R., Kinderman, P., Johnson, T., Abbott, R., & Hayhurst, H. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.4.313 · Cited by 566
Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552
Self-citationYung, A. R., Nelson, B., Baker, K., Buckby, J. A., Baksheev, G., & Cosgrave, E. M. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802607188 · Cited by 371
Self-citationYung, A. R., Buckby, J. A., Cotton, S. M., Cosgrave, E. M., Killackey, E. J., Stanford, C., Godfrey, K., & McGorry, P. D. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj018 · Cited by 264
Staging: a neglected dimension in psychiatric classification
Fava, G. A., & Kellner, R. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03362.x · Cited by 252 · cited 2×
“, 2007a), depressive disorders (Fava and Kellner, 1993; Hetrick et al., 2008), eating disorders (Le Grange and Loeb, 2007), and bipolar disorders (Berk et al.”
BackgroundMcGorry, P. D. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.859 · Cited by 219
Self-citationThe Elephant on the Couch: Side-Effects of Psychotherapy
Berk, M., & Parker, G. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670903107559 · Cited by 216 · cited 1×
“…treatments at this stage of illness is proven (we note, however, that psychosocial interventions are not without side effects, e.g. increasing emotional arousal, and that further research into the possible negative impact of psychosocial interventions is required (see Berk and Parker, 2009)).”
BackgroundSelf-citationCatatonia: Disappeared or Under-Diagnosed?
van der Heijden, F. M. M. A., Tuinier, S., Arts, N. J. M., Hoogendoorn, M. L. C., Kahn, R. S., & Verhoeven, W. M. A. (2005) · Psychopathology · doi:10.1159/000083964 · Cited by 207 · cited 1×
“…to the most severe manifestations of schizophrenia such as catatonia and the severely disorganised phenotypes becoming rare in modern clinical settings, again suggesting an impact of treatment on limiting the expression of the most deteriorated forms of the disorder (van der Heijden et al., 2005).”
BackgroundMcGorry, P. D. (2007) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01338.x · Cited by 191 · cited 5×
“…staging model is a heuristic framework for developing more refined forms of diagnosis, developing and evaluating intervention strategies, and for studying the variables and processes underlying the evolution of psychiatric disorder (McGorry, 2007a; McGorry et al., 2006; McGorry et al., 2008).”
BackgroundMethodResultSelf-citationEarly Identification and Intervention in Depressive Disorders: Towards a Clinical Staging Model
Hetrick, S. E., Parker, A. G., Hickie, I. B., Purcell, R., Yung, A. R., & McGorry, P. D. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000140085 · Cited by 186 · cited 2×
“, 2007a), depressive disorders (Fava and Kellner, 1993; Hetrick et al., 2008), eating disorders (Le Grange and Loeb, 2007), and bipolar disorders (Berk et al.”
BackgroundSelf-citationGlutathione: a novel treatment target in psychiatry
Berk, M., Ng, F., Dean, O., Dodd, S., & Bush, A. I. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.001 · Cited by 183 · cited 4×
“Furthermore, lithium, antidepressants, atypical antipsychotics and anticonvulsants all share effects on oxidative stress defences (Berk et al., 2008b).”
BackgroundSelf-citationCompliance with antipsychotic treatment
Oehl, M., Hummer, M., & Fleischhacker, W. W. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.00016.x · Cited by 151 · cited 2×
“(2002) found that approximately 60% of FEP patients at a specialised treatment servicewere not compliant or inadequately compliant with antipsychotic medication, consistent with other reports in the field (Oehl et al., 2000; Perkins, 1999).”
ResultCognitively oriented psychotherapy for early psychosis (COPE): A 1‐year follow‐up
Jackson, H., McGorry, P., Henry, L., Edwards, J., Hulbert, C., Harrigan, S., Dudgeon, P., Francey, S., Maude, D., Cocks, J., et al. (2001) · British Journal of Clinical Psychology · doi:10.1348/014466501163481 · Cited by 72
Self-citationThe therapeutic alliance: is it necessary or sufficient to engender positive outcomes?
Macneil, C. A., Hasty, M. K., Evans, M., Redlich, C., & Berk, M. (2009) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2009.00372.x · Cited by 31 · cited 1×
“Critical issues in long-term adherence are engagement with the treating clinician or team, the therapeutic alliance and illness acceptance (Macneil et al., 2009).”
BackgroundSelf-citation
Cited by
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
Brissos, S., Veguilla, M. R., Taylor, D., & Balanzá-Martinez, V. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314540297 · Cited by 297
Santesteban-Echarri, O., Paino, M., Rice, S., González-Blanch, C., McGorry, P., Gleeson, J., & Alvarez-Jimenez, M. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.09.007 · Cited by 268
Self-citationStaging in bipolar disorder: from theoretical framework to clinical utility
Berk, M., Post, R., Ratheesh, A., Gliddon, E., Singh, A., Vieta, E., Carvalho, A. F., Ashton, M. M., Berk, L., Cotton, S. M., et al. (2017) · World Psychiatry · doi:10.1002/wps.20441 · Cited by 216
Self-citationMcGorry, P., & Nelson, B. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2868 · Cited by 211
Self-citationDell’Osso, B., Glick, I. D., Baldwin, D. S., & Altamura, A. C. (2013) · Psychopathology · doi:10.1159/000338608 · Cited by 118
Metadata
- Authors
- Francey, S. M., Nelson, B., Thompson, A., Parker, A. G., Kerr, M., Macneil, C., Fraser, R., Hughes, F., Crisp, K., Harrigan, S., Wood, S. J., Berk, M., & McGorry, P. D.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 119
- Issue
- 1-3
- Pages
- 1-10
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W1967710354
- Cited by
- 100
- References
- 23
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.